Skip to content

Incentive Programs for Female Substance Abusers Who Smoke - 3

Incentive Programs for Female Substance Abusers Who Smoke

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00064922
Enrollment
90
Registered
2003-07-16
Start date
2002-01-31
Completion date
2006-04-30
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Keywords

nicotine dependence

Brief summary

The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

Detailed description

This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.

Interventions

BEHAVIORALBehavior Therapy

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol * Nicotine Dependent as confirmed by DSM-IV checklist * Current cigarette smoker * Breath CO reading of at least 8 ppm at the time of the initial study screening * Current client with the Shields for Families (Shields) treatment programs

Exclusion criteria

* Non-smoker

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026